MARCHESELLI, Raffaella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.363
EU - Europa 2.913
AS - Asia 2.540
SA - Sud America 342
AF - Africa 81
Continente sconosciuto - Info sul continente non disponibili 79
OC - Oceania 15
Totale 12.333
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.228
GB - Regno Unito 1.306
SG - Singapore 757
CN - Cina 691
IT - Italia 432
HK - Hong Kong 306
VN - Vietnam 253
DE - Germania 250
BR - Brasile 239
SE - Svezia 223
FR - Francia 148
FI - Finlandia 127
RU - Federazione Russa 112
BD - Bangladesh 109
UA - Ucraina 108
IN - India 77
CA - Canada 76
TR - Turchia 74
KR - Corea 53
BG - Bulgaria 43
AR - Argentina 40
ID - Indonesia 40
MA - Marocco 40
IQ - Iraq 30
MX - Messico 24
BE - Belgio 20
ES - Italia 20
NL - Olanda 19
PL - Polonia 19
EC - Ecuador 16
PK - Pakistan 16
AE - Emirati Arabi Uniti 15
ZA - Sudafrica 15
CO - Colombia 14
IE - Irlanda 14
AU - Australia 13
CH - Svizzera 13
CZ - Repubblica Ceca 13
JP - Giappone 13
MY - Malesia 12
SA - Arabia Saudita 12
UZ - Uzbekistan 10
AT - Austria 9
IR - Iran 9
VE - Venezuela 9
AZ - Azerbaigian 8
CL - Cile 8
CR - Costa Rica 8
LT - Lituania 8
PH - Filippine 8
HU - Ungheria 7
JM - Giamaica 7
DO - Repubblica Dominicana 6
JO - Giordania 6
PY - Paraguay 6
BZ - Belize 5
KE - Kenya 5
KG - Kirghizistan 5
KZ - Kazakistan 5
DK - Danimarca 4
TH - Thailandia 4
TN - Tunisia 4
BO - Bolivia 3
EG - Egitto 3
EU - Europa 3
GP - Guadalupe 3
LB - Libano 3
NO - Norvegia 3
NP - Nepal 3
PE - Perù 3
PS - Palestinian Territory 3
UY - Uruguay 3
BH - Bahrain 2
CY - Cipro 2
ET - Etiopia 2
IL - Israele 2
KH - Cambogia 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
Totale 12.243
Salva come PNG Salva come JPEG
Città #
Southend 1.070
Ashburn 697
Fairfield 592
Santa Clara 539
Singapore 490
Woodbridge 458
Hong Kong 299
Houston 278
Chandler 269
Seattle 249
San Jose 225
Wilmington 223
Ann Arbor 206
Cambridge 205
Jacksonville 203
Beijing 193
Dearborn 163
Nyköping 162
Hefei 138
Council Bluffs 136
New York 117
London 114
Modena 98
Los Angeles 88
Chicago 82
Helsinki 78
Ho Chi Minh City 70
Frankfurt am Main 66
The Dalles 62
San Diego 57
Milan 54
Hanoi 51
Seoul 50
Shanghai 44
Buffalo 42
Princeton 42
Sofia 42
Munich 39
Eugene 38
Moscow 36
Columbus 35
Salt Lake City 35
Casablanca 32
Lauterbourg 32
Izmir 30
Bremen 26
Bologna 25
Jakarta 24
Dallas 22
Montreal 22
Phoenix 21
São Paulo 21
Brussels 19
Elk Grove Village 19
Rome 19
Boardman 17
Da Nang 17
Redwood City 17
Warsaw 17
Falls Church 16
Orem 16
Toronto 15
Turku 15
Des Moines 14
Dublin 14
New Delhi 14
Tampa 14
Brooklyn 13
Denver 13
Nanjing 13
Fremont 12
Guangzhou 12
Manchester 12
Baghdad 11
Poplar 11
Tokyo 11
Buenos Aires 10
Chennai 10
Dong Ket 10
Paris 10
Boston 9
Kunming 9
North Bergen 9
Norwalk 9
Ottawa 9
Rho 9
Dhaka 8
Gurugram 8
Indiana 8
San Giuliano Milanese 8
San Mateo 8
Sterling 8
Stockholm 8
Tashkent 8
Baku 7
Boydton 7
Carpi 7
Johannesburg 7
Lahore 7
Nuremberg 7
Totale 8.941
Salva come PNG Salva come JPEG
Nome #
Therapy-related myeloid neoplasm in non-hodgkin lymphoma survivors. 626
Absolute monocyte count at diagnosis could improve the prognostic role of early FDG-PET in classical Hodgkin lymphoma patients 533
A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up 462
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: A 16-year follow-up study 414
Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study 396
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: Final results of a phase II study conducted by the Fondazione Italiana Linfomi 367
Body composition and inflammation impact in non-small cell lung cancer patients treated by first-line immunotherapy 367
Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study 353
A concise review of lenalidomide therapy for follicular lymphoma 349
Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: Results of a large multicenter study involving 990 patients 338
The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of Pet-guided treatments 330
Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story. 322
Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis 322
Phase II Study of Velcade (R) Plus Mabthera (R) In Relapsed Follicular Lymphomas. 318
Risk for second malignancies in non-Hodgkin's lymphoma survivors: a meta-analysis 313
Risk of second primary malignancy in breast cancer survivors: A nested population-based case-control study 310
Analysis of Frequency and Risk Factors for Developing Bisphosphonate Associated Osteonecrosis of the Jaw. 309
Radiation therapy improves treatment outcome in patients with diffuse large B-cell lymphoma 308
Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma 300
Incidence and outcome of Myelodysplastic Syndromes in province of Modena 293
BISPHOSPHONATES (BP) RELATED OSTEONECROSIS OF THE JAW (ONJ): A LONG TERM FOLLOW UP (FU) OF A SERIES OF 35 CASES OBSERVED BY GISL 292
INCIDENCE AND SURVIVAL OF MYELOID MALIGNANCIES IN 1102 PATIENTS IN PROVINCE OF MODENA, NORTHERN ITALY 288
A RANDOMIZED PHASE II STUDY (GISL - MM03 TRIAL) WITH ORAL MELPHALAN+ PREDNISONE (MP) VERSUS MELPHALAN, + PREDNISONE + THALIDOMIDE (MPT) FOR NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA 288
Biological effects of Atra and Arsenic Trioxide on short term cultures of non-M3 leukemic blasts 285
Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients 283
Efficacy Controls and Long-Term Follow-Up of Patients (Pts) Treated with FC Plus Rituximab for Relapsed Follicular NHL. Session Type: Publication Only 280
Incidence and outcome of chronic myeloproliferative disorders: A population-based study from a cancer registry in northern Italy 273
A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplant 272
: Late toxicity and quality of life (QOL) after treatment for Hodgkin disease (HD): A Gruppo Italiano Studio Linfomi (GISL) cohort study on 223 patients 270
Second Malignancy After Treatment for Non-Hodgkin Lymphoma: a Systematic Review and a Meta-Analysis of Population-Based and Cohort Studies 260
Secondary malignancies after treatment of aggressive non-Hodgkin lymphoma: A GISL cohort study on 1259 patients 255
SECOND MALIGNANCIES AFTER TREATMENT FOR INDOLENT LYMPHOMA: A 16 YEARS FOLLOW-UP STUDY 251
VALIDATION OF ABSOLUTE LYMPHOCYTE COUNT / REVISED IPI (ALC/R-IPI) SCORE MODEL, AS A PROGNOSTIC INDEX FOR DIFFUSE LARGE-B-CELL LYMPHOMA IN RITUXIMAB ERA 243
Rituximab (R) in Combination with Fludarabine (F) and Cyclophosphamide (C) in Relapsed Follicular Lymphoma (FL) Patients (pts).Final Results of FC + R Phase II Trial by the GISL. 241
Bisphosphonates-associated osteonecrosis of the jaw: A long-term follow-up of a series of 35 cases observed by GISL and evaluation of its frequency over time 235
Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma 232
Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting 216
Treatment of patients with recurrent follicular lymphoma with rituximab in combination with fludarabine and cyclophosphamide 186
Rituximab in combination with chemotherapy has improved survival of patients with follicular lymphoma 178
Epidemiologia degli infortuni lavorativi in minori: risultati di una indagine condotta nella città di Modena nel periodo gennaio-giugno 2000. 175
Totale 12.333
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.130
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022844 0 86 80 49 24 74 49 50 107 61 156 108
2022/2023854 92 111 60 78 98 118 26 87 93 10 55 26
2023/2024683 24 26 49 63 145 59 146 48 17 16 35 55
2024/20251.761 66 19 42 121 373 276 124 108 195 56 140 241
2025/20263.523 241 144 204 385 586 222 446 171 369 368 212 175
2026/2027273 102 171 0 0 0 0 0 0 0 0 0 0
Totale 12.333